Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

(BIOA) (BIOA) Competitors

(BIOA) logo

BIOA vs. ACAD, JANX, ZLAB, AMRX, CPRX, GERN, BLTE, LBPH, IDYA, and ARWR

Should you be buying (BIOA) stock or one of its competitors? The main competitors of (BIOA) include ACADIA Pharmaceuticals (ACAD), Janux Therapeutics (JANX), Zai Lab (ZLAB), Amneal Pharmaceuticals (AMRX), Catalyst Pharmaceuticals (CPRX), Geron (GERN), Belite Bio (BLTE), Longboard Pharmaceuticals (LBPH), IDEAYA Biosciences (IDYA), and Arrowhead Pharmaceuticals (ARWR). These companies are all part of the "pharmaceutical preparations" industry.

(BIOA) vs.

(BIOA) (NYSE:BIOA) and ACADIA Pharmaceuticals (NASDAQ:ACAD) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and community ranking.

(BIOA) currently has a consensus price target of $42.33, indicating a potential upside of 121.18%. ACADIA Pharmaceuticals has a consensus price target of $25.56, indicating a potential upside of 56.15%. Given (BIOA)'s stronger consensus rating and higher possible upside, equities analysts plainly believe (BIOA) is more favorable than ACADIA Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
(BIOA)
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
ACADIA Pharmaceuticals
0 Sell rating(s)
6 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.65

ACADIA Pharmaceuticals has a net margin of 13.83% compared to (BIOA)'s net margin of 0.00%. ACADIA Pharmaceuticals' return on equity of 25.83% beat (BIOA)'s return on equity.

Company Net Margins Return on Equity Return on Assets
(BIOA)N/A N/A N/A
ACADIA Pharmaceuticals 13.83%25.83%14.71%

(BIOA) has higher earnings, but lower revenue than ACADIA Pharmaceuticals.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(BIOA)N/AN/AN/AN/AN/A
ACADIA Pharmaceuticals$726.44M3.75-$61.29M$0.7820.99

In the previous week, ACADIA Pharmaceuticals had 22 more articles in the media than (BIOA). MarketBeat recorded 23 mentions for ACADIA Pharmaceuticals and 1 mentions for (BIOA). ACADIA Pharmaceuticals' average media sentiment score of 0.09 beat (BIOA)'s score of 0.00 indicating that ACADIA Pharmaceuticals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
(BIOA)
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
ACADIA Pharmaceuticals
6 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

96.7% of ACADIA Pharmaceuticals shares are held by institutional investors. 1.8% of (BIOA) shares are held by company insiders. Comparatively, 28.3% of ACADIA Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

ACADIA Pharmaceuticals received 602 more outperform votes than (BIOA) when rated by MarketBeat users. However, 73.30% of users gave (BIOA) an outperform vote while only 73.20% of users gave ACADIA Pharmaceuticals an outperform vote.

CompanyUnderperformOutperform
(BIOA)Outperform Votes
291
73.30%
Underperform Votes
106
26.70%
ACADIA PharmaceuticalsOutperform Votes
893
73.20%
Underperform Votes
327
26.80%

Summary

ACADIA Pharmaceuticals beats (BIOA) on 10 of the 13 factors compared between the two stocks.

Get (BIOA) News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIOA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIOA vs. The Competition

Metric(BIOA)Pharmaceutical IndustryMedical SectorNYSE Exchange
Market Cap$686.17M$6.59B$5.21B$20.34B
Dividend YieldN/A8.14%5.53%3.48%
P/E RatioN/A6.7882.8840.70
Price / SalesN/A357.041,246.7619.01
Price / CashN/A53.8240.9121.67
Price / BookN/A10.617.204.72
Net IncomeN/A$153.27M$119.63M$987.19M

(BIOA) Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIOA
(BIOA)
1.563 of 5 stars
$19.14
+3.8%
$42.33
+121.2%
+149,431.3%$686.17MN/A0.00N/A
ACAD
ACADIA Pharmaceuticals
3.7145 of 5 stars
$16.37
+1.2%
$25.56
+56.2%
-25.6%$2.72B$929.24M21.04510Insider Trade
Analyst Revision
News Coverage
JANX
Janux Therapeutics
3.9316 of 5 stars
$50.31
+8.2%
$67.70
+34.6%
+452.3%$2.64B$8.08M-43.0030Analyst Forecast
News Coverage
ZLAB
Zai Lab
2.9609 of 5 stars
$26.43
+2.8%
$52.50
+98.6%
-3.9%$2.63B$266.72M-9.282,175
AMRX
Amneal Pharmaceuticals
3.2246 of 5 stars
$8.39
+0.8%
$10.00
+19.2%
+88.5%$2.60B$2.68B-12.347,700Insider Trade
News Coverage
CPRX
Catalyst Pharmaceuticals
4.7111 of 5 stars
$21.48
+1.7%
$31.14
+45.0%
+55.0%$2.56B$460.48M17.95167
GERN
Geron
3.574 of 5 stars
$4.07
+1.2%
$7.05
+73.2%
+108.7%$2.46B$240,000.00-12.72141
BLTE
Belite Bio
1.8341 of 5 stars
$80.23
-2.7%
$89.00
+10.9%
+112.9%$2.46BN/A-72.2820
LBPH
Longboard Pharmaceuticals
1.7786 of 5 stars
$59.80
+0.1%
$59.56
-0.4%
+1,358.5%$2.34BN/A-26.8220Positive News
IDYA
IDEAYA Biosciences
4.1879 of 5 stars
$26.79
+0.7%
$53.67
+100.3%
-15.2%$2.32B$3.92M-11.5080High Trading Volume
ARWR
Arrowhead Pharmaceuticals
3.6338 of 5 stars
$18.54
+1.4%
$45.33
+144.5%
-36.0%$2.30B$240.74M-3.97400Upcoming Earnings
Analyst Forecast
News Coverage

Related Companies and Tools


This page (NYSE:BIOA) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners